BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11264774)

  • 1. Nontransplant therapy for dialysis-related amyloidosis.
    Copley JB; Lindberg JS
    Semin Dial; 2001; 14(2):94-8. PubMed ID: 11264774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis-related amyloidosis.
    Dzido G; Sprague SM
    Minerva Urol Nefrol; 2003 Jun; 55(2):121-9. PubMed ID: 12847416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-microglobulin and renal bone disease.
    Wada T; Miyata T; Sakai H; Kurokawa K
    Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.
    Jaradat MI; Moe SM
    Semin Dial; 2001; 14(2):107-12. PubMed ID: 11264777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis.
    Suzuki K; Shimazaki M; Kutsuki H
    Ther Apher Dial; 2003 Feb; 7(1):104-7. PubMed ID: 12921124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kidney and bone update : the 5-year history and future of CKD-MBD. Treatment for dialysis-related amyloidosis update].
    Yamamoto S; Kazama JJ; Narita I
    Clin Calcium; 2012 Jul; 22(7):1089-98. PubMed ID: 22750942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J; Floege J; Ehlerding G; Koch KM
    Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new therapeutic approach to dialysis amyloidosis: intensive removal of beta 2-microglobulin with adsorbent column.
    Gejyo F; Homma N; Hasegawa S; Arakawa M
    Artif Organs; 1993 Apr; 17(4):240-3. PubMed ID: 8498903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
    Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
    Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis-related amyloidosis: Is it still relevant?
    Kaneko S; Yamagata K
    Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
    Miyata T; Inagi R; Kurokawa K
    Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis-related amyloidosis: history and clinical manifestations.
    Danesh F; Ho LT
    Semin Dial; 2001; 14(2):80-5. PubMed ID: 11264771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
    Floege J; Schäffer J; Koch KM; Shaldon S
    Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis.
    Abe T; Uchita K; Orita H; Kamimura M; Oda M; Hasegawa H; Kobata H; Fukunishi M; Shimazaki M; Abe T; Akizawa T; Ahmad S
    Kidney Int; 2003 Oct; 64(4):1522-8. PubMed ID: 12969174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis-related amyloidosis: importance of biocompatibility and age.
    Jadoul M
    Nephrol Dial Transplant; 1998; 13 Suppl 7():61-4. PubMed ID: 9870440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.